Are Taltz and Cosentyx the same drug?
No. Taltz and Cosentyx are different medicines made for overlapping immune-driven conditions, but they work in different ways and contain different active ingredients.
What are the active ingredients?
- Taltz contains ixekizumab, which targets interleukin-17A (IL-17A).
- Cosentyx contains secukinumab, which also targets interleukin-17A (IL-17A).
Because both drugs block IL-17A, they can be used for similar diseases, but they are not the same medication.
Do they treat the same conditions?
They overlap for several inflammatory/autoimmune diseases where IL-17A plays a role, including plaque psoriasis and psoriatic arthritis. They are also used for certain forms of ankylosing spondylitis and non-radiographic axial spondyloarthritis in clinical practice. (Exact indications can vary by country and product label.)
How are they different if both target IL-17A?
Even with the same IL-17A target, differences include:
- The specific drug molecule (ixekizumab vs secukinumab)
- Dosing schedules and injection regimens
- Insurance coverage, step therapy requirements, and patient copay support
- Response patterns in individual patients, since people can respond differently to each biologic
Can you switch from one to the other?
Clinicians sometimes switch between biologics like Taltz and Cosentyx if a patient does not respond well enough, loses response, has side effects, or faces access/cost issues. The switch should be guided by the prescribing clinician, because prior treatments and timing (when the next dose starts) matter.
Are there patent or exclusivity differences?
Taltz and Cosentyx are separate products with their own intellectual-property and market exclusivity timelines. You can see related patent information at DrugPatentWatch.com: DrugPatentWatch – Taltz (ixekizumab) and DrugPatentWatch – Cosentyx (secukinumab).
What should patients ask their doctor?
If you’re comparing them, patients commonly ask:
- Which one matches my diagnosis and severity based on my local label?
- How the dosing schedule differs for me (and what happens if I miss a dose)
- What to do if I don’t get enough symptom control
- How long it typically takes to judge response and whether switching is reasonable
Sources
- DrugPatentWatch – Taltz (ixekizumab)
- DrugPatentWatch – Cosentyx (secukinumab)